Expertise in
6
conditions

Dr. Claudia T. Martorell

Infectious Disease
57 Mulberry St, 
Springfield, MA 
Offers Telehealth
Expertise in
6
conditions
57 Mulberry St, 
Springfield, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Claudia Martorell is an Infectious Disease provider in Springfield, Massachusetts. Dr. Martorell is highly rated in 6 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Her clinical research consists of co-authoring 19 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Puerto Rico School Of Medicine
Specialties
Infectious Disease
Licenses
Internal Medicine in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

57 Mulberry St, Springfield, MA 01105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Enrollment Status: Completed
Publish Date: May 30, 2024
Intervention Type: Drug
Study Drugs: Gepotidacin, Ceftriaxone, Azithromycin
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living With HIV/AIDS (PLWHA) With Non-Infectious Diarrhea
A Phase 4 Open Label Study to Assess the Safety and Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in People Living With HIV/AIDS (PLWHA) With Non-Infectious Diarrhea
Enrollment Status: Completed
Publish Date: October 22, 2021
Intervention Type: Drug
Study Drug: Crofelemer delayed-release tablets
Study Phase: Phase 4
Lyme Test Indication Combinations (LyTIC) Study
Lyme Test Indication Combinations (LyTIC) Study
Enrollment Status: Terminated
Publish Date: December 13, 2018
Intervention Type: Diagnostic test
Evaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence to Treatment
Evaluation of Wirelessly Observed Therapy to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence to Treatment
Enrollment Status: Unknown
Publish Date: December 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
Enrollment Status: Terminated
Publish Date: September 11, 2018
Intervention Type: Drug
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
Enrollment Status: Terminated
Publish Date: January 17, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

19 Total Publications

Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV care.
Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV care.
Journal: HIV research & clinical practice
Published: January 31, 2025
Similar Doctors
Expertise in
11
conditions
Dr. Daniel J. Skiest
Infectious Disease
Expertise in
11
conditions
Dr. Daniel J. Skiest
Infectious Disease

Baystate Medical Practices Inc

3350 Main St, 
Springfield, MA 
 (2.2 mi)
413-794-9338
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Skiest is an Infectious Disease provider in Springfield, Massachusetts. Dr. Skiest is highly rated in 11 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Skiest is currently accepting new patients.

Expertise in
9
conditions
Dr. Albert I. Ko
Infectious Disease
Expertise in
9
conditions
Dr. Albert I. Ko
Infectious Disease

Yale University

20 York St, 
New Haven, CT 
 (58.1 mi)
203-785-4638
Languages Spoken:
English

Albert Ko is an Infectious Disease provider in New Haven, Connecticut. Dr. Ko is highly rated in 9 conditions, according to our data. His top areas of expertise are Leptospirosis, Zika Virus Disease, COVID-19, and Severe Acute Respiratory Syndrome (SARS).

Expertise in
2
conditions
Dr. Alan L. Rothman
Infectious Disease
Expertise in
2
conditions
Dr. Alan L. Rothman
Infectious Disease
55 Lake Ave N, Department Of Infectious Disease, 
Worcester, MA 
 (43.7 mi)
508-856-4182
Languages Spoken:
English

Alan Rothman is an Infectious Disease provider in Worcester, Massachusetts. Dr. Rothman is highly rated in 2 conditions, according to our data. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Sepsis, and Zika Virus Disease.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Martorell's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile